In our AAA patient cohort the circulating levels of IgM were decreased, of note in other cardiovascular diseases IgM have been described as protective [41,42,43], so further studies are needed in order to clarify if this will be the case in AAA. The gene discussed is CD40LG; the disease is cardiovascular disorder.